Kahlua,
thx for your posting. Great that you liked my analysis on both stocks. Isn't it funny - there are 2 smaller players in an industry that is outperforming almost all the rest of the S&P sector indices - cosmetics, otc/health, personal care etc. When you go to cbs.marketwatch.com you can look at sectoral and intra-group performance levels.
Now while the seasoned "battleships" like CLX, PYX, G, PG or RDEN had a nice ride up, those smaller vessels seemed to have an even better time when the rising tide came. (so much for the proverb the rising tide lifts all the boats <g>). The real funny instance with both: PARL & CCAM is that both were dropped like a rock when the slowing economy news first trickled in this January.
and both companies succesfully adressed their internal problems last year: PARL getting down the A/R to a "friendly" party and CCAM restructuring back to profitability. I expect profitable levels in both companies for the forseeable future. PARL might end up on the acquisition trail if the price is right to the CEO, Mr. Lekach.
You have to know that actually a research report that was disseminated by Reuters in mid May started my interest into the group. Back then they covered Japanese beauty conglomerate KAO and what smaller players they might acquire next. They came up with Alberto Culver, PYX, DL etc. Well I analyzed the WHOLE GROUP and found even better deal another "layer" below: CCAM and PARL. If PYX, DL etc. are takeover targets, why not even smaller entities with proven brands that could be deployed ubiquitous with the right PR muscle ??
I even looked into bigger players and will have to dig up more into Revlon but hey, even the Perelman ugly duckling could get into the black this year if they continue as they did.
On CCAM, the quarterly report should be out over the next 2 weeks. Stay tuned, I expect another 5 cents profit, as last quarter
best wishes
CROSSY |
